Bain Capital, through Bain Capital Tech Opportunities, invested BRL450m (~USD81.6m) for a 43% stake in Brazil-based healthcare software company Bionexo at a reported BRL1.1b (~USD199.5m) valuation, facilitating a partial exit for Prisma Capital and Apus. Read more here and here